Moolec Science (NASDAQ:MLEC) and Worldwide Webb Acquisition (NASDAQ:WWAC) Financial Contrast

Moolec Science (NASDAQ:MLEC) and Worldwide Webb Acquisition (NASDAQ:WWAC) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Risk & Volatility

Moolec Science has a beta of -0.47, indicating that its stock price is 147% less volatile than the S&P 500. Comparatively, Worldwide Webb Acquisition has a beta of 0.07, indicating that its stock price is 93% less volatile than the S&P 500.

Insider and Institutional Ownership

0.1% of Moolec Science shares are owned by institutional investors. Comparatively, 49.1% of Worldwide Webb Acquisition shares are owned by institutional investors. 19.9% of Moolec Science shares are owned by company insiders. Comparatively, 43.0% of Worldwide Webb Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Moolec Science and Worldwide Webb Acquisition”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$5.63 million	5.67	-$7.31 million	($0.20)	-4.15
Worldwide Webb Acquisition	N/A	N/A	N/A	N/A	N/A

Worldwide Webb Acquisition has lower revenue, but higher earnings than Moolec Science.

Analyst Recommendations

This is a summary of current ratings and price targets for Moolec Science and Worldwide Webb Acquisition, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0	0	1	0	3.00
Worldwide Webb Acquisition	0	0	0	0	0.00

Moolec Science presently has a consensus target price of $6.00, indicating a potential upside of 623.76%. Given Moolec Science’s stronger consensus rating and higher probable upside, analysts plainly believe Moolec Science is more favorable than Worldwide Webb Acquisition.

Profitability

This table compares Moolec Science and Worldwide Webb Acquisition’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Moolec Science	-129.97%	-97.95%	-27.91%
Worldwide Webb Acquisition	N/A	N/A	N/A

Summary

Worldwide Webb Acquisition beats Moolec Science on 6 of the 10 factors compared between the two stocks.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

About Worldwide Webb Acquisition

Worldwide Webb Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of direct-to-consumer brands, amazon-centric, online marketplace, food tech, new media, digital health, software-as-a-service, fintech, and others. The company was incorporated in 2021 and is based in Orem, Utah.